Oxaflozane

This classification denotes an antidepressant agent with the molecular formula C14H18F3NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V4WLW77V5Q, chemically known as 4-isopropyl-2-(alpha,alpha,alpha-trifluoro-m-tolyl)morpholine but generally known as oxaflozane, which bears US NIH Compound Identifier 71915. European Medicines Agency schedules Oxaflozane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09486MIG. The term OXAFLOZANE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules oxaflozane in its Anatomical Therapeutic Chemical (ATC) Classification. OXAFLOZANE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxaflozane under HS 29349990 and SITC 51579. As of Q4 2014, OXAFLOZANE remains the US FDA Preferred Term for this commodity. Oxaflozane bears US NLM identifiers UMLS ID C0069709 and NCI Concept Code C75175. SMILES: FC(F)(F)c1ccc(C2OCCN(C2)C(C)C)cc1.